The Who

  • Global biopharmaceutical manufacturer
  • Specialists in rare diseases
  • Operating in 80 countries, including US, UK, and Japan

The Challenge

  • Recent acquisition meant closer integration of technology between both businesses
  • Part of transition involved the evaluation of branch/office locations
  • Integration would occur on a global scale

The Solution

  • Servium provided 4 on-site consultants to cover technical architecture, project management, and installation services
  • Plan for global integration of offices proposed
  • When each office was confirmed as staying, consultants proposed what technology would be required for each location
  • Every office re-fitted with refreshed network technology
  • Where possible, legacy technology repurposed to sweat assets for longer
  • Solution deployed in Australian, South American, European, and Middle Eastern offices

The Benefits

  • Maximised previous technology investments
  • Avoided the cost of permanent staffing for an interim project
  • No need to take on full-time staff thanks to outsourcing of consultants via Servium
  • Integration of offices completed across multiple countries
  • Successfully completed on-time and on-budget

Why Servium?

  • Longstanding, trusted relationship with customer
  • Access to expertise on a global scale
  • Existing managed services contract secured better commercials and priority resource
  • Highly flexible at every stage of project